Can gabapentin 100 mg combined with clonazepam cause respiratory depression in a 62‑year‑old woman?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, this combination can stop you from breathing—respiratory depression is a serious risk that requires careful monitoring.

The combination of gabapentin 100 mg with clonazepam poses a documented risk of respiratory depression in a 62-year-old woman, particularly if other risk factors are present. 1 The FDA drug label for clonazepam explicitly warns that concomitant use of benzodiazepines and CNS depressants may result in profound sedation, respiratory depression, coma, and death 1.

Understanding the Risk

Gabapentin combined with benzodiazepines creates additive respiratory depression through different mechanisms:

  • Benzodiazepines (clonazepam) work at GABA-A receptors, depressing the central ventilatory response to hypoxia and hypercapnea 2
  • Gabapentinoids bind to voltage-gated calcium channels and inhibit neurotransmitter release 3
  • When combined, evidence shows dangerous respiratory depression can occur 4

Recent research confirms this concern: concomitant opioid-gabapentinoid use increased respiratory depression risk by 73% (HR: 1.73; 95% CI: 1.53-1.96) compared to opioids alone 5. While this study examined opioid combinations, the mechanism of CNS depression is similar with benzodiazepines.

Risk Factors That Increase Danger

Your risk is higher if you have:

  • Respiratory conditions (COPD, asthma, sleep apnea) 1, 6
  • Renal impairment requiring dose adjustment—25.9% of gabapentin users need this 7
  • Age ≥65 years—consumption increases 2.6-4.0 times in older adults 7
  • Polypharmacy (≥5 medications)—present in 81% of gabapentinoid users 7
  • Concomitant alcohol or other CNS depressants 8

The 2019 American Geriatrics Society Beers Criteria specifically recommends avoiding concurrent use of opioids with benzodiazepines AND avoiding opioids with gabapentinoids due to increased fall risk and respiratory depression 9. This same caution applies to benzodiazepine-gabapentinoid combinations.

Clinical Monitoring Algorithm

If this combination must be used:

  1. Start with the lowest effective doses of both medications 1
  2. Monitor respiratory rate, oxygen saturation, and level of sedation at each dose adjustment 10
  3. Watch for excessive sedation—this typically precedes respiratory depression 10
  4. Avoid additional CNS depressants (alcohol, opioids, other sedatives) 9, 1
  5. Check renal function—76.1% of gabapentin users with impaired GFR receive inappropriate doses 7
  6. Consider prescribing naloxone if opioids are also involved, though it won't reverse benzodiazepine or gabapentinoid effects 10

Common Pitfalls to Avoid

  • Don't assume 100 mg gabapentin is "too low" to cause problems—respiratory depression occurs even at therapeutic doses when combined with benzodiazepines 4
  • Don't overlook renal function—gabapentin requires dose adjustment with decreased creatinine clearance 3
  • Don't abruptly discontinue either medication—both can cause withdrawal seizures 1
  • Don't add a third CNS depressant—the 2025 AHA guidelines note that flumazenil may not fully reverse respiratory depression in mixed overdoses 8

When to Seek Alternatives

Consider alternative pain or anxiety management if:

  • Respiratory disease is present
  • Already taking opioids or other CNS depressants
  • History of substance use disorder
  • Age >75 years with multiple comorbidities

The 2019 Lancet Psychiatry review emphasizes that gabapentinoids taken with benzodiazepines carry risks similar to opioid combinations, with evidence showing "dangerous respiratory depression can occur" 4.

Bottom line: This combination CAN stop your breathing, especially with dose escalation, additional medications, or underlying respiratory/renal disease. Close monitoring is essential, and alternative treatments should be strongly considered.

Related Questions

In a housebound patient taking pregabalin 150 mg daily and as‑needed gabapentin 300 mg every 12 hours, should the gabapentin be discontinued and only pregabalin continued to avoid additive central nervous system depression?
Are there any drug interactions or additive central nervous system effects when hydroxyzine is taken with gabapentin?
In a 40‑year‑old man with hyperlipidemia, Barrett’s esophagus, depression, Charcot‑Marie‑Tooth disease, and new‑onset hypertension (BP 142‑146/86‑98 mm Hg) who is taking gabapentin 600 mg three times daily, tramadol 50 mg twice to three times daily, pravastatin 20 mg daily, trazodone 100 mg at bedtime, buspirone 15 mg daily, quetiapine (Seroquel) 100 mg daily, brexpiprazole (Rexulti) 0.5 mg daily, and omeprazole 40 mg twice daily, what is the ideal first‑line antihypertensive agent for him?
What are the most significant adverse effects of gabapentin?
Can a 73-year-old woman with left-hand paresthesia and uncontrolled diabetes mellitus start gabapentin?
What are the causes of leg cramps?
Is it appropriate to prescribe Pylera (metronidazole and tetracycline) for a patient with elevated transaminases?
What is the age‑based method for estimating a child's weight?
How frequently can platelet-rich plasma (PRP) be administered for skin scar treatment?
What are the recommended antibiotics for treating Stenotrophomonas maltophilia infection?
What is the appropriate treatment and follow‑up for a 69‑year‑old patient with urinary‑tract infection symptoms and a urine culture growing Streptococcus gallolyticus ssp. pasteurianus?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.